Epstein-Barr virus-associated post-transplant lymphoproliferative disorders: beyond chemotherapy treatment.

Shahid, Sanam; Prockop, Susan E

Shahid, Sanam; Prockop, Susan E.

Afiliação

Shahid S; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Prockop SE; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

Cancer Drug Resist ; 4: 646-664, 2021.

Article em En | MEDLINE | ID: mdl-34485854

Palavras-chave

CD20 monoclonal antibody; EBV; EBV CTLs; EBV-specific cytotoxic T lymphocytes; Epstein-Barr virus; PTLD; Post-transplant lymphoproliferative disease; chemoimmunotherapy; immunotherapy; rituximab

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancer Drug Resist Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google